抗肿瘤药物临床试验终点技术指导原则

2019-10-31 国家药品监督管理局药品审评中心(CDE)

抗肿瘤药物临床试验终点技术指导原则

中文标题:

抗肿瘤药物临床试验终点技术指导原则

发布日期:

2019-10-31

简要介绍:

抗肿瘤药物临床试验终点技术指导原则

相关资料下载:
[AttachmentFileName(sort=100, fileName=抗肿瘤药物临床试验终点技术指导原则)] GetToolGuiderByIdResponse(projectId=1, id=9a91a1c00181e90d, title=抗肿瘤药物临床试验终点技术指导原则, enTitle=, guiderFrom=, authorId=null, author=, summary=抗肿瘤药物临床试验终点技术指导原则, cover=, journalId=null, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心(CDE), associationIntro=国家药品监督管理局药品审评中心(CDE), copyright=0, guiderPublishedTime=Thu Oct 31 05:42:46 CST 2019, originalUrl=, linkOutUrl=, content=抗肿瘤药物临床试验终点技术指导原则, tagList=[TagDto(tagId=6475, tagName=抗肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3618, appHits=44, showAppHits=0, pcHits=2284, showPcHits=3103, likes=62, shares=1, comments=0, approvalStatus=1, publishedTime=Thu Oct 31 05:42:46 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 05:42:46 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 09:55:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=抗肿瘤药物临床试验终点技术指导原则)])
抗肿瘤药物临床试验终点技术指导原则
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=381958, encodeId=0974381958de, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Apr 20 21:48:11 CST 2020, time=2020-04-20, status=1, ipAttribution=)]
    2020-04-20 lovetcm

    不错

    0